A5093393822- Cannabis and Cannabinoid Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pulmonary Hypertension Research and Treatments
- Homelessness and Social Issues
- Substance Abuse Treatment and Outcomes
- Sarcoidosis and Beryllium Toxicity Research
Deccan College of Medical Sciences
2023-2024
Pulmonary hypertension (PH) often complicates idiopathic pulmonary fibrosis (IPF), a progressive parenchymal lung disease. We investigated predictors of PH in IPF hospitalizations the United States. identified hospital- izations with or without using National Inpatient Sample (2018) and relevant ICD-10-CM codes. com- pared demographics, comorbidities, prevalence, its multivariable adjusted for confounders among patients IPF. In 2018, 30,335 from 30,259,863 had IPF, which 8,075 (26.6%) PH....
With the increase in popularity of cannabis and its use lack large-scale data on venous thromboembolism pulmonary embolism (PE), we used a nationally representative cohort young adults (aged 18-44 years) to compare odds admissions in-hospital mortality PE with without disorder (CUD).